EverQuote, Inc.
For the period ended Sep 30, 2026. Filed Nov 3, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 3, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2026-06-30; filed 2026-08-04.
0001193125-26-332775
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsOther InformationCurrent report: 10-Q
Period ended 2026-09-30; filed 2026-11-03.
0001193125-26-445464
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsOther InformationThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 14 previous paragraphs and 12 current paragraphs.
9 unchanged; 0 reworded; 3 added; 5 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 2 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (3)
Current report
We did not purchase any of our registered equity securities during the period from July 1, 2026 to September 30, 2026.
Current report
On November 2, 2026, the board of directors on the recommendation of the Compensation Committee, approved amendments to the outperformance pRSUs granted to the Company’s executive officers in 2025 (the “Executive pRSUs”). The amendments (i) redefine Adjusted EBITDA, for purposes of the Executive pRSUs only, as a percentage of the Company’s GAAP revenue in order to determine achievement of the awards’ performance targets, subject to a downward adjustment in certain circumstances; and (ii) update and clarify the change in control provisions. Except for the amendments described above and other administrative revisions, the material terms of Executive pRSUs remain unchanged, including the measurement dates and number of pRSUs. The amendments address the possible impact on 2027 Adjusted EBITDA of the Company’s expected increased investment in AI. The amendments are intended to preserve the pRSUs’ original purpose of incentivizing achievement of the Company’s long-term model while supporting potential investments the Company believes may be necessary to drive long-term growth and stockholder value. This description is qualified in its entirety by the form of Amended and Restated Performance-Based Restricted Stock Unit Agreement, which is filed as Exhibit 10.3 to this Quarterly Report on Form 10-Q and is incorporated by reference herein.
Removed paragraphs (5)
Previous report
The following table presents information with respect to shares of Class A common stock repurchased by EverQuote, Inc. during the three months ended June 30, 2026:
Previous report
(1) Average price paid per share includes broker commissions and costs associated with the repurchase.
Previous report
(2) On July 22, 2025, our board of directors authorized the repurchase of up to $50.0 million in shares of the Company’s Class A common stock. Repurchased shares are retired and resume the status of authorized but unissued shares of common stock.
Previous report
(1) Mr. Neble’s Rule 10b5-1 Trading Plan provides for the sale of an indeterminable number of shares of common stock from the settlement of restricted stock units (“RSUs”). The number of shares of common stock is unknown as the number will vary based on the extent to which vesting conditions of the RSUs are satisfied, the market price of the Company’s common stock at the time of settlement and the amount of shares that would otherwise be issuable on each settlement date of a covered RSU that are sold or withheld in an amount sufficient to satisfy applicable tax withholding obligations.
Previous report
(2) Mr. Shields’ Rule 10b5-1 Trading Plan provides for the sale of an indeterminable number of shares of common stock from the settlement of restricted stock units (“RSUs”). The number of shares of common stock is unknown as the number will vary based on the extent to which vesting conditions of the RSUs are satisfied, the market price of the Company’s common stock at the time of settlement and the amount of shares that would otherwise be issuable on each settlement date of a covered RSU that are sold or withheld in an amount sufficient to satisfy applicable tax withholding obligations.